USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
暂无分享,去创建一个
R. DePinho | Jun Li | Y. A. Wang | Chang-Jiun Wu | Jianhua Zhang | Shan Jiang | A. Kimmelman | P. Lorenzi | D. Spring | Pingping Hou | L. Tan | W. Yao | Alec C. Kimmelman | Liang Yan | Zecheng Yang | Xingdi Ma | Qiang Zhang | Xin Zhou
[1] R. Andersson,et al. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data , 2020, Scientific Reports.
[2] D. Sabatini,et al. Nutrient regulation of mTORC1 at a glance , 2019, Journal of Cell Science.
[3] R. DePinho,et al. USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation , 2019, Genes & development.
[4] E. Petricoin,et al. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer , 2019, Nature Medicine.
[5] S. Hanash,et al. Syndecan1 is a critical mediator of macropinocytosis in pancreatic cancer , 2019, Nature.
[6] J. Asara,et al. Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC–MS/MS , 2019, Nature Protocols.
[7] J. Yap,et al. Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers , 2019, Nature Medicine.
[8] M. V. Recouvreux,et al. Macropinocytosis: A Metabolic Adaptation to Nutrient Stress in Cancer , 2017, Front. Endocrinol..
[9] N. Hay,et al. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? , 2016, Nature Reviews Cancer.
[10] D. Tuveson,et al. The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1 , 2015, Cell.
[11] K. Ross,et al. Transcriptional control of the autophagy-lysosome system in pancreatic cancer , 2015, Nature.
[12] S. Clare,et al. Ubiquitin Specific Protease 21 Is Dispensable for Normal Development, Hematopoiesis and Lymphocyte Differentiation , 2015, PloS one.
[13] H. Arai,et al. Small GTPases and phosphoinositides in the regulatory mechanisms of macropinosome formation and maturation , 2014, Front. Physiol..
[14] Shan Jiang,et al. Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer , 2014, Cell.
[15] Joseph Rosenbluh,et al. KRAS and YAP1 Converge to Regulate EMT and Tumor Survival , 2014, Cell.
[16] Christian M. Metallo,et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells , 2013, Nature.
[17] Gerald C. Chu,et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.
[18] J. Asara,et al. A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue , 2012, Nature Protocols.
[19] Marc Liesa,et al. Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.
[20] S. Gygi,et al. Defining the Human Deubiquitinating Enzyme Interaction Landscape , 2009, Cell.
[21] E. Mandelkow,et al. The tau of MARK: a polarized view of the cytoskeleton. , 2009, Trends in biochemical sciences.
[22] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. DePinho,et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.
[24] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.